Back to Search Start Over

Hypoxia drives the formation of lung micropapillary adenocarcinoma-like structure through hypoxia-inducible factor-1α.

Authors :
Umeda D
Harada A
Motooka D
Tahara S
Kurashige M
Kido K
Takashima T
Kiyokawa H
Ukon K
Matsui T
Matsumoto S
Shintani Y
Okuzaki D
Kikuchi A
Nojima S
Morii E
Source :
Scientific reports [Sci Rep] 2024 Dec 30; Vol. 14 (1), pp. 31642. Date of Electronic Publication: 2024 Dec 30.
Publication Year :
2024

Abstract

Micropapillary adenocarcinoma (MPC) is an aggressive histological subtype of lung adenocarcinoma (LUAD). MPC is composed of small clusters of cancer cells exhibiting inverted polarity. However, the mechanism underlying its formation is poorly understood. Here we show that hypoxia is involved in MPC formation. Hypoxia induced the formation of MPC-like structures (MLSs) in a three-dimensional culture system using A549 human LUAD cells, and HIF-1α was indispensable for MLS formation. RNA sequencing analysis demonstrated that A549 cells forming MLSs exhibited a gene expression signature similar to that of lung MPC. Moreover, MLS formation enhanced the resistance of A549 cells to natural killer cell cytotoxicity. Our findings suggest that hypoxia drives lung MPC formation through HIF-1α and that immune escape from natural killer cells might underlie the aggressiveness of MPC.<br />Competing Interests: Declarations. Competing interests: The authors declare no competing interests. Ethical approval: All experimental protocols involving human specimens were approved by the Ethics Review Board of the Graduate School of Medicine, Osaka University (approval no. 15234) and carried out in accordance with the committee’s guidelines and regulations. The study was performed in accordance with the Declaration of Helsinki.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
2045-2322
Volume :
14
Issue :
1
Database :
MEDLINE
Journal :
Scientific reports
Publication Type :
Academic Journal
Accession number :
39738173
Full Text :
https://doi.org/10.1038/s41598-024-80280-x